Tag Archives: Actos

Diabetes Drug Actos Caused Bladder Cancer and Wrongful Death of Oklahoma Man, Alleges Lawsuit Filed by Parker Waichman LLP

Posted on by


New York, New York (PRWEB) June 25, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of an Oklahoma man who developed bladder cancer and subsequently died, allegedly after taking the diabetes drug Actos (pioglitazone). The suit was filed on Might 23, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1237). It is one of thousands of circumstances that have been filed as component of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (six:11-md-2299). Takeda Pharmaceuticals, America Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc. Takeda Pharmaceutical Firm Limited and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs Steering Committee in the litigation.

&#13

According to the Complaint, the Plaintiff began taking Actos to treat his Variety 2 diabetes in November 2008. In January 2010, he was diagnosed with bladder cancer. He died in October 2012, allegedly due to the fact of Actos side effects. The lawsuit filed on his behalf alleges that the Defendants knew about the threat of bladder cancer but did not disclose this details to customers in order to protect economic interests. The Plaintiff alleges that Actos triggered pain and suffering, emotional distress and substantially decreased the Plaintiffs capability to take pleasure in life. The suit is also seeking damages for loss of consortium on behalf of the Plaintiffs spouse.

&#13

On June 15, 2011, the U.S. Meals and Drug Administration (FDA) warned that taking Actos for far more than a year could considerably increase the risk of bladder cancer. The safety label on Actos was updated to address this threat.

&#13

Some analysis research assistance the notion of a hyperlink amongst Actos and bladder cancer. The British Medical Journal published a study on Might 31, 2012, that revealed Actos customers were twice as probably to create bladder cancer right after two years. Then, on July three, 2012, the Canadian Health-related Association Journal reported that sufferers taking the medication have been 22 % much more likely to get bladder cancer.

&#13

Parker Waichman LLP continues to offer cost-free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved a single have been diagnosed with bladder cancer after taking Actos, please contact their workplace by going to yourlawyer.com. Free of charge case evaluations are also accessible by calling 1-800-LAW-Info (1-800-529-4636).

&#13

Get in touch with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Lawyer &#13

(800) LAW-Info &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Parker Waichman LLP Represents Pennsylvania Man in Lawsuit Alleging Actos Triggered his Bladder Cancer

Posted on by


New York, New York (PRWEB) June 07, 2013

Parker Waichman LLP, a national law firm dedicated to defending the victims of defective drugs, has filed a lawsuit on behalf of a Pennsylvania man who allegedly created bladder cancer soon after taking the diabetes drug Actos (pioglitazone). The suit was filed on May 23rd in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1170) as part of the multidistrict litigation entitled In Re: Actos (Pioglitazone) Items Liability Litigation (six:11-md-2299). Takeda Pharmaceuticals, America Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc. Takeda Pharmaceutical Company Limited and Eli Lilly and Business have been named as Defendants.

&#13

According to the Complaint, the Plaintiff started taking Actos in November 2003 to treat his Kind two diabetes. By August 2006, he was diagnosed with bladder cancer. The suit alleges that Actos brought on the bladder cancer due to its defective nature. In addition, the suit alleges that the Defendants knew about the risk of bladder cancer but failed to disclose this data to shoppers in order to safeguard financial interests. The Plaintiff is alleging that Actos brought on discomfort and suffering, emotional distress and economic damages in the type of healthcare costs and lost wages. The suit is also in search of damages for loss of consortium on behalf of the Plaintiffs spouse.

&#13

In June 2011, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year could significantly boost the risk of bladder cancer. The security label on Actos was updated to address this danger*. Further analysis supports the link between Actos and bladder cancer. Final May possibly, a study in the British Health-related Journal** identified that Actos users were twice as likely to create bladder cancer right after two years. That July, the Canadian Healthcare Association Journal*** discovered that sufferers taking the medication had been 22 % far more probably to get bladder cancer. &#13

*http://www.fda.gov/Drugs/DrugSafety/ucm266555.htm&#13

**(http://www.bmj.com/content material/344/bmj.e3645) &#13

***(http://www.cmaj.ca/content material/early/2012/07/03/cmaj.112102)

&#13

Parker Waichman LLP continues to offer you free of charge legal consultations to victims of Actos injuries, which includes bladder cancer, heart troubles, and eye injuries. If you or a loved 1 had been diagnosed with bladder cancer following taking Actos, please contact their office by visiting yourlawyer.com. Totally free case evaluations are also available by calling 1 800 LAW Information (1-800-529-4636).

&#13

Make contact with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Attorney &#13

(800) LAW-Information &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Actos Lawsuits: Bernstein Liebhard LLP Notes Far more Than 1,500 Situations Now Filed in Federal Litigation

Posted on by


New York, New York (PRWEB) June 02, 2013

Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

&#13

According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed troubles associated to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the possible for long-term use of Actos, a type two diabetes drug manufactured by Takeda Pharmaceuticals, to trigger or worsen bladder cancer. (In re: Actos Solution Liability Litigation, MDL No. 2299)

&#13

As we continue to receive inquiries about prospective Actos lawsuits from individuals who allege extended-term use of the drug triggered their bladder cancer, we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is at the moment offering free Actos bladder cancer lawsuit evaluations to individuals who developed bladder cancer right after utilizing the medication for an extended period of time.

&#13

Actos Bladder Cancer Lawsuit Allegations

&#13

The federal multidistrict litigation for Actos bladder cancer lawsuits was produced in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Meals and Drug Administration issued an alert warning the public that long-term use of the medication might increase a individuals threat for establishing bladder cancer.* There are now 1,500 instances pending in in the Western District of Louisiana, exactly where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as effectively, with the initial trial is slated to begin on January 27, 2014, with the second to adhere to on April 14, 2014.

&#13

In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed more than the medication employed to manage blood-sugar levels in type 2 diabetes sufferers are pending in state litigations in Illinois and California.**

&#13

Individuals who took Actos and developed bladder cancer following lengthy-term use of the drug may possibly be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Understand more about how to file an Actos lawsuit by going to Bernstein Liebhard LLPs web site or by calling a single of the Firms Actos lawyers at 800-511-5092.

&#13

*FDA, June 15, 2011 fda.gov/drugs/drugsafety/ucm259150.htm&#13

**bloomberg.com/news/2013-05-01/takeda-gets-six-five-million-diabetes-drug-verdict-thrown-out.html

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, which includes these who have been harmed by harmful drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP&#13

10 East 40th Street&#13

New York, New York 10016&#13

800-511-5092

&#13

Attorney Advertising.